Weekly Roundup for APRIL 2, 2021: Recent Publications in Women’s Mental Health

Dose-effect of maternal serotonin reuptake inhibitor use during pregnancy on birth outcomes: A prospective cohort study. Molenaar NM, Houtman D, Bijma HH, Brouwer ME, Burger H, Hoogendijk WJG, Bockting CLH, Kamperman AM, Lambregtse-van den Berg MP.  J Affect Disord. 2020 Apr 15;267:57-62. Maternal SRI dose at 36 weeks of gestation was significantly associated with birth… Read More »

With stories and puppets, environmentalist battles to save Indonesia’s mangroves

INDRAMAYU, Indonesia – Caked in mud up to their knees, a small group of Indonesian youngsters plant mangrove saplings along a stretch of exposed coastline next to the Java Sea under the watchful eye of local environmentalist Samsudin. A former school teacher, Samsudin has now dedicated his life to conservation and uses puppetry and storytelling… Read More »

Latest snapshot of the coronavirus impact

LATEST COVID-19 DEVELOPMENTS: * The introduction of general practice clinics to the national coronavirus vaccination program has enabled the number of doses delivered to triple in the past couple of weeks. * Acting Chief Medical Officer Michael Kidd said daily and weekly numbers were only likely to improve as the number of vaccine clinics doubles… Read More »

Easily The Best Egg Salad

A combination of savory, spicy, crunchy, and a little sweet — this is Easily the Best Egg Salad recipe to have in mind for a convenient meal! As much as we try to slow down, there are times when we need a little bit of convenience and ease to best support yourself, especially on busy… Read More »

Trump knew testing Covid-19 vaccines would take months, Woodward book shows

Trump also suggests that’s why he initially pushed so hard for the use of the malaria drug hydroxychloroquine, because the malaria drug had already been tested and approved for other uses. “Well, we’re doing great on vaccines,” Woodward quotes Trump as saying in his latest book, “Rage.” “The problem with a vaccine is a vaccine… Read More »

FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia

FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia Morristown, N.J. March 31, 2021 — Althera Pharmaceuticals, a company focused on heart health, today announced the FDA approval of Roszet (rosuvastatin and ezetimibe) tablets, as an adjunct to diet, for treatment of elevated low-density lipoprotein cholesterol (LDL-C) in adult… Read More »

Latest snapshot of the coronavirus impact

LATEST COVID-19 DEVELOPMENTS: * A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians. * The Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation met on Saturday morning and Acting Chief Medical Officer Michael Kidd said no changes to the AstraZeneca rollout… Read More »